SMYD3 and cancer: However, a recent paper by Thomenius et al. has called into question the role of SMYD3 in cancer cell growth by showing that SMYD3i or SMYD3 KO with the novel CRISPR/Cas9 technology failed to impair cell proliferation of hundreds of cancer cell lines of different origin and genetic background.